Damien Fink

Damien Fink

Company: Century Therapeutics

Job title: Director

Seminars:

Panel Discussion: Innovative Molecular Assays through Revolutionizing Genomic Analysis in Cell Therapy Development 3:00 pm

Harnessing the power of next-generation sequencing for comprehensive genomic profiling, enabling precise characterization of genetic variations, gene expression profiles, and molecular pathways relevant to cell therapy efficacy and safety. Exploring the applications of digital PCR in quantitative nucleic acid analysis, offering enhanced sensitivity, accuracy, and reproducibility for detecting rare mutaons, monitoring gene expression levels, and…Read more

day: Track C - Molecular Assay (Day One - Afternoon)

Navigating Characterization Strategies in Cell Therapy Development with Evolving Insights from FDA Guidance 11:00 am

In the rapidly advancing field of cell therapy, developers face significant challenges in characterizing their products to meet regulatory standards. The FDA has provided evolving guidance on what is required for effective characterization, which includes understanding product attributes, ensuring consistency, and demonstrating safety and efficacy. Join us to: Understand how cell therapy developers are adapting…Read more

day: Workshop C - Analytical Development

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.